Dainippon Sumitomo Pharma Co. Ltd.

Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$868
Current Liabilities (US$ Millions)$1,493
Total Assets (US$ Millions)$3,502
Long Term Debt$233
Return on Equity5.48%
Revenue (US$ Millions)$3,349
Total Company Assets$5,879
Revenue Growth (%)8.57%
Net Income (US$ Millions)$205
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$3,709
Profit Margin (%)6.13%
Debt To Equity Ratio (%)0.06%
Inventory Turnover$495